Syndromic Retinopathy

Gene: AFG3L2

Red List (low evidence)

AFG3L2 (AFG3 like matrix AAA peptidase subunit 2)
EnsemblGeneIds (GRCh38): ENSG00000141385
EnsemblGeneIds (GRCh37): ENSG00000141385
OMIM: 604581, ClinGen, DECIPHER
AFG3L2 is in 14 panels

2 reviews

Zornitza Stark (Victorian Clinical Genetics Services)

Red List (low evidence)

OA has only been associated with a specific variant in this gene, R468C. The variant is de novo in some of the families, suggesting a hotspot rather than founder effect.

Optic atrophy rather than retinopathy, not within panel scope.
Created: 21 Aug 2020, 5:07 p.m. | Last Modified: 23 Dec 2025, 1:27 p.m.
Panel Version: 0.239

Mode of inheritance
BOTH monoallelic and biallelic, autosomal or pseudoautosomal

Phenotypes
Spastic ataxia 5, autosomal recessive (MIM#614487); Spinocerebellar ataxia 28 (MIM#610246); Optic atrophy 12, MIM# 618977

Publications

Bryony Thompson (Royal Melbourne Hospital)

Green List (high evidence)

The onset of the recessive form of ataxia is usually in infancy or childhood. The dominantly inherited form of ataxia is mostly adult onset, but onset in childhood has been reported.
Sources: Expert list
Created: 16 Apr 2020, 5:25 p.m.

Mode of inheritance
BOTH monoallelic and biallelic, autosomal or pseudoautosomal

Phenotypes
Spastic ataxia 5, autosomal recessive MIM#614487; Spinocerebellar ataxia 28 MIM#610246

Publications

Details

Mode of Inheritance
BOTH monoallelic and biallelic, autosomal or pseudoautosomal
Sources
  • Expert Review Red
  • Expert list
  • RetNet
  • Victorian Clinical Genetics Services
Phenotypes
  • Spastic ataxia 5, autosomal recessive (MIM#614487)
  • Spinocerebellar ataxia 28 (MIM#610246)
  • Optic atrophy 12, MIM# 618977
OMIM
604581
ClinGen
AFG3L2
DECIPHER
AFG3L2
Clinvar variants
Variants in AFG3L2
Penetrance
None
Publications
Panels with this gene

History Filter Activity

23 Dec 2025, Gel status: 1

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: afg3l2 has been classified as Red List (Low Evidence).

23 Dec 2025, Gel status: 1

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services)

Phenotypes for gene: AFG3L2 were changed from to Spastic ataxia 5, autosomal recessive (MIM#614487); Spinocerebellar ataxia 28 (MIM#610246); Optic atrophy 12, MIM# 618977

23 Dec 2025, Gel status: 1

Set publications

Zornitza Stark (Victorian Clinical Genetics Services)

Publications for gene: AFG3L2 were set to

23 Dec 2025, Gel status: 1

Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services)

Mode of inheritance for gene: AFG3L2 was changed from Unknown to BOTH monoallelic and biallelic, autosomal or pseudoautosomal

23 Dec 2025, Gel status: 1

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: afg3l2 has been classified as Red List (Low Evidence).

7 Feb 2020, Gel status: 3

Created, Added New Source, Set mode of inheritance

Bryony Thompson (Royal Melbourne Hospital)

gene: AFG3L2 was added gene: AFG3L2 was added to Syndromic Retinopathy. Sources: Expert Review Green,RetNet Mode of inheritance for gene: AFG3L2 was set to Unknown